These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9684798)

  • 1. Warfarin resistance is associated with a protein component of the vitamin K 2,3-epoxide reductase enzyme complex in rat liver.
    Cain D; Hutson SM; Wallin R
    Thromb Haemost; 1998 Jul; 80(1):128-33. PubMed ID: 9684798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
    Cain D; Hutson SM; Wallin R
    J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular mechanism for genetic warfarin resistance in the rat.
    Wallin R; Hutson SM; Cain D; Sweatt A; Sane DC
    FASEB J; 2001 Nov; 15(13):2542-4. PubMed ID: 11641264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin resistance in a French strain of rats.
    Lasseur R; Longin-Sauvageon C; Videmann B; Billeret M; Berny P; Benoit E
    J Biochem Mol Toxicol; 2005; 19(6):379-85. PubMed ID: 16421894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats.
    Wajih N; Sane DC; Hutson SM; Wallin R
    J Biol Chem; 2004 Jun; 279(24):25276-83. PubMed ID: 15075329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.
    Hammed A; Matagrin B; Spohn G; Prouillac C; Benoit E; Lattard V
    J Biol Chem; 2013 Oct; 288(40):28733-42. PubMed ID: 23928358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.
    Rost S; Fregin A; Ivaskevicius V; Conzelmann E; Hörtnagel K; Pelz HJ; Lappegard K; Seifried E; Scharrer I; Tuddenham EG; Müller CR; Strom TM; Oldenburg J
    Nature; 2004 Feb; 427(6974):537-41. PubMed ID: 14765194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of the coumarin anticoagulant targeted vitamin K epoxide reduction system. Study of kinetic parameters in susceptible and resistant mice (Mus musculus domesticus).
    Lasseur R; Grandemange A; Longin-Sauvageon C; Berny P; Benoit E
    J Biochem Mol Toxicol; 2006; 20(5):221-9. PubMed ID: 17009238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in VKORC1 and its effect on enzymatic activity in Japanese warfarin-resistant rats.
    Tanaka KD; Kawai YK; Ikenaka Y; Harunari T; Tanikawa T; Fujita S; Ishizuka M
    J Vet Med Sci; 2013 Feb; 75(2):135-9. PubMed ID: 23018795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of vitamin K epoxide reductase.
    Tie JK; Stafford DW
    Vitam Horm; 2008; 78():103-30. PubMed ID: 18374192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieu.
    Chen X; Jin DY; Stafford DW; Tie JK
    Blood; 2018 Nov; 132(18):1974-1984. PubMed ID: 30089628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Puerarin offsets the anticoagulation effect of warfarin in rats by inducing rCyps, upregulating vitamin K epoxide reductase and inhibiting thrombomodulin.
    Ge B; Zhang Z; Lam TT; Zuo Z
    Biopharm Drug Dispos; 2017 Jan; 38(1):33-49. PubMed ID: 27925234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats.
    MacNicoll AD
    Biochim Biophys Acta; 1985 May; 840(1):13-20. PubMed ID: 3995080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the gene for vitamin K epoxide reductase.
    Li T; Chang CY; Jin DY; Lin PJ; Khvorova A; Stafford DW
    Nature; 2004 Feb; 427(6974):541-4. PubMed ID: 14765195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pesticide resistance in wild mammals--mechanisms of anticoagulant resistance in wild rodents.
    Ishizuka M; Tanikawa T; Tanaka KD; Heewon M; Okajima F; Sakamoto KQ; Fujita S
    J Toxicol Sci; 2008 Aug; 33(3):283-91. PubMed ID: 18670159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.
    Guenthner TM; Cai D; Wallin R
    Biochem Pharmacol; 1998 Jan; 55(2):169-75. PubMed ID: 9448739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
    Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
    Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The VKORC1 ER-luminal loop mutation (Leu76Pro) leads to a significant resistance to warfarin in black rats (Rattus rattus).
    Takeda K; Ikenaka Y; Fourches D; Tanaka KD; Nakayama SMM; Triki D; Li X; Igarashi M; Tanikawa T; Ishizuka M
    Pestic Biochem Physiol; 2021 Mar; 173():104774. PubMed ID: 33771253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of bacterial disulfide bond formation by the anticoagulant warfarin.
    Dutton RJ; Wayman A; Wei JR; Rubin EJ; Beckwith J; Boyd D
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):297-301. PubMed ID: 20018758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.